The Valley Desk

NCT05557045 · Interventional trial

A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

Overall registry status Active not recruiting

Phase 1

Conditions Advanced Cancer, Anaplastic Thyroid Cancer (ATC), Colorectal Cancer (CRC), Melanoma, Metastatic Cancer, Non-small Cell Lung Cancer (NSCLC), Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov